710 related articles for article (PubMed ID: 26168936)
1. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.
Xu XJ; Zheng P; Ren GP; Liu ML; Mu J; Guo J; Cao D; Liu Z; Meng HQ; Xie P
Mol Biosyst; 2014 Apr; 10(4):813-9. PubMed ID: 24457555
[TBL] [Abstract][Full Text] [Related]
3. Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.
Chen JJ; Liu Z; Fan SH; Yang DY; Zheng P; Shao WH; Qi ZG; Xu XJ; Li Q; Mu J; Yang YT; Xie P
Sci Rep; 2014 Jul; 4():5855. PubMed ID: 25068480
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of urinary metabolite biomarkers for major depressive disorder.
Zheng P; Wang Y; Chen L; Yang D; Meng H; Zhou D; Zhong J; Lei Y; Melgiri ND; Xie P
Mol Cell Proteomics; 2013 Jan; 12(1):207-14. PubMed ID: 23111923
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
6. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
[TBL] [Abstract][Full Text] [Related]
8. Differential urinary metabolites related with the severity of major depressive disorder.
Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective.
Hashimoto K
Adv Clin Chem; 2018; 84():81-99. PubMed ID: 29478517
[TBL] [Abstract][Full Text] [Related]
10. Urinary metabolite signature in bipolar disorder patients during depressive episode.
Chen JJ; Xie J; Zeng L; Zhou CJ; Zheng P; Xie P
Aging (Albany NY); 2019 Feb; 11(3):1008-1018. PubMed ID: 30721880
[TBL] [Abstract][Full Text] [Related]
11. Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.
Zheng P; Chen JJ; Zhou CJ; Zeng L; Li KW; Sun L; Liu ML; Zhu D; Liang ZH; Xie P
Transl Psychiatry; 2016 Nov; 6(11):e955. PubMed ID: 27845778
[TBL] [Abstract][Full Text] [Related]
12. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific urinary biomarkers for diagnosing bipolar disorder.
Chen JJ; Huang H; Zhao LB; Zhou DZ; Yang YT; Zheng P; Yang DY; He P; Zhou JJ; Fang L; Xie P
PLoS One; 2014; 9(12):e115221. PubMed ID: 25531985
[TBL] [Abstract][Full Text] [Related]
14. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review.
MacDonald K; Krishnan A; Cervenka E; Hu G; Guadagno E; Trakadis Y
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):122-137. PubMed ID: 30411484
[TBL] [Abstract][Full Text] [Related]
16. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
[TBL] [Abstract][Full Text] [Related]
17. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses.
Isomura S; Onitsuka T; Tsuchimoto R; Nakamura I; Hirano S; Oda Y; Oribe N; Hirano Y; Ueno T; Kanba S
J Affect Disord; 2016 Jan; 190():800-806. PubMed ID: 26625092
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of argininosuccinate synthase as a candidate urinary biomarker for major depressive disorder.
Wu D; Peng Y; Zhou J; Yang YT; Rao CL; Bai SJ; Zhou XY; Chen J; Liao L; Liang ZH; Yang DY; Xie P
Clin Chim Acta; 2015 Dec; 451(Pt B):142-8. PubMed ID: 26394130
[TBL] [Abstract][Full Text] [Related]
20. Towards a blood-based diagnostic panel for bipolar disorder.
Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
